Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Gianluca Gaïdano, Lodovico Terzi-di-Bergamo et al.|Blood|2015Cited by 215
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agentsVittorio Emanuele Muccio, Paola Omedè, Elona Saraci et al.|Cytometry Part B Clinical Cytometry|2015Cited by 54
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Berit J. Brinkmann et al.|Nature Communications|2022Cited by 42
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Marco Ladetto, Daniela Capello et al.|Haematologica|2011Cited by 16